DEVONNA MAGUET: Open Payments
NPI 1992066559 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 17 payments from 6 companies in 2025. Trend: 2023 $292 · 2024 $120 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $180 |
| ABBVIE INC. | 3 | $51 |
| Tonix Medicines, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: FARXIGA, VRAYLAR, TONMYA, QULIPTA, JARDIANCE, CAPLYTA, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
